Cancer Heterogeneity and Plasticity ISSN 2818-7792
Cancer Heterogeneity and Plasticity 2024;1(1):0003 | https://doi.org/10.47248/chp2401010003
Original Research Open Access
Metastatic colorectal cancer cells upregulate SMLR1 that interacts with tumor-associated macrophages in the liverChi Wut Wong 1,2,3,† ‡ , Lihua Wang 3,† , Jorge Prado Balcazar 3 , Yong Chen 3,4 , Xiling Shen 1,5,‡
Correspondence: Xiling Shen
Academic Editor(s): Dean Tang
Received: Mar 30, 2024 | Accepted: Jun 10, 2024 | Published: Jul 18, 2024
Cite this article: Wong C, Wang L, Balcazar J, Chen Y, Shen X. Metastatic colorectal cancer cells upregulate SMLR1 that interacts with tumor-associated macrophages in the liver. Cancer Heterog Plast 2024; 1(1):0003. https://doi.org/10.47248/chp2401010003
Colorectal cancer liver metastasis (CRLM) is the most common form of metastatic colorectal cancer (CRC), one of the leading causes of cancer deaths. The CRLM microenvironment tends to be more immunosuppressive, making immunotherapy less effective. By transcriptomics analysis, we discovered that small leucine-rich protein 1 (SMLR1) is upregulated in CRC liver metastases compared to primary tumors. High SMLR1 expression by the cancer is associated with poor prognosis. Proteomics analysis and cell retention assay revealed associations between SMLR1 and mannose receptor C-type 1 (MRC1, CD206) and sialic acid binding Ig-like lectin 1 (SIGLEC1, CD169) expressed on tumor-associated macrophages in the metastatic liver microenvironment. These data provide evidence that cancer cells modulate their metastatic niche via the upregulation of SMLR1 and physical interaction with immunosuppressive macrophages in the liver.
KeywordsColorectal cancer, liver metastasis, small leucine-rich protein 1 (SMLR1), tumor-associated macrophages
Copyright © 2024 Pivot Science Publications Corp. - unless otherwise stated | Terms and Conditions | Privacy Policy